- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 53.44M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $4.05M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $22.9M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $26.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.71M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.05M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $11.21M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $35.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $36.38M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $39.73M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $42.78M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $113.99M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $118.77M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 40.8M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $112K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.56M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $83.38M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $90.04M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.20 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $7.38M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $860K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$8.1M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$7.99M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.21M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $7.08M |
| Revenue | Q1 2025 · Mar 31, 2024 | $9.29M |